New Press Release
Press Release Source: CDEX, Inc.
Mount Carmel West Hospital Partners with CDEX to Implement ValiMed Medication Validation Solution
Wednesday January 11, 1:45 pm ET
CDEX ValiMed System Chosen by Mount Carmel West to Verify Compounded Medications and Doses, Validate Narcotic Returns, and Screen for Counterfeit Pharmaceuticals
ROCKVILLE, Md. & COLUMBUS, Ohio--(BUSINESS WIRE)--Jan. 11, 2006--Mount Carmel West Hospital has selected the CDEX (OTCBB:CEXI - News) ValiMed system to perform end-product testing of compounded intravenous medications in its pharmacy departments, and validation of returned narcotics in its operating room suites and nursing units. The CDEX ValiMed medication verification system was developed to give clinicians a quick, cost effective, and simple tool to further ensure medication safety by verifying medications are correctly compounded.
ADVERTISEMENT
In a process that takes only seconds, ValiMed uses patent pending technology to validate compounded doses of high-risk medications prior to dispensing. The solution creates an added level of safety in the medication dispensing process, and is also used to validate narcotic returns as well as screen for counterfeit medications.
"Medication safety is our top priority at Mount Carmel and ValiMed enhances the safeguard procedures we currently have in place without adding additional resources. The ValiMed product offers us the opportunity to validate end-products being dispensed from the pharmacy and to validate returned narcotics," said Joe Melucci, Director of Pharmacy at Mount Carmel West.
"CDEX is very excited to be working with Mount Carmel to extend our new validation technology to a community hospital setting," said Jim Griffin, CEO of CDEX.
The CDEX ValiMed solution utilizes a discrete energy source to produce unique return photon signatures, which are referenced against a database of unique medication spectral fingerprints to validate pharmaceuticals. The device validates that the correct medications in the correct amounts have been added to the dose during the compounding process.
About Mount Carmel West
With a history of serving the community since 1886, Mount Carmel offers a broad range of healthcare services in the central Ohio region and treats more than a half million patients each year. The healthcare system includes three hospitals - Mount Carmel East, Mount Carmel West, and Mount Carmel St. Ann's; outpatient services; home care; hospice care; home medical equipment services; an ambulance and mobile intensive care service; a community outreach program for the poor and under-served; a college of nursing; and a Medicare HMO. Mount Carmel is a member of Trinity Health, based in Novi, Michigan. For more information about Mount Carmel, visit the healthcare system's Website at www.mountcarmelhealth.com
About CDEX, Inc.
CDEX Inc. is a technology development company with a current focus on developing and marketing products using chemical detection and validation technologies. At present, CDEX is devoting its resources to two distinct areas: (i) identification of substances of concern (e.g., explosives and illegal drugs for homeland security); and (ii) validation of substances for anti-counterfeiting, brand protection and quality assurance (e.g., validation of prescription medication and detection of counterfeit or sub-par products for brand protection). ValiMed is one line of CDEX products for the healthcare market. CDEX is headquartered in Rockville, Maryland with its research and development laboratory in Tucson, Arizona. For more information, visit www.cdex-inc.com and www.valimed.com.
Any statements made in this press release, which contain information that is not historical, are essentially forward-looking. Many forward-looking statements can be identified by the use of words such as "expects," "plans," "may," "anticipates," "believes," "should," "intends," "estimates," and other words of similar meaning. These statements are subject to risks and uncertainties that cannot be predicted or quantified and, consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks are detailed from time-to-time in filings with the Securities and Exchange Commission. There is no obligation to publicly update any forward-looking statements.
Contact:
CDEX, Inc.
Media Contact:
Brad Wills, 301-767-1919
bwills@wills-pr.com
AI
